DC CHEMICALS · SCREENING COLLECTION
An in-stock collection of established benchmark lipids, research candidates and supporting materials. Choose the products that fit your research and request a tailored quotation.
CHOOSE YOUR SCOPE
Select familiar reference lipids, explore additional candidates, or request the full catalog. Each product links to its own specifications, available packs and research information.
Products are supplied as pure lipid materials. Quantity per compound, final composition, packaging, pricing and dispatch timing are confirmed in your quotation.
Inventory scope confirmed on 25 October 2026. Stock quantities may change.
Selection & quotation tools · Updated 25 October 2026
BUILD YOUR SELECTION
Prices in USD, checked 25 October 2026. Select a pack and number of packs, or choose “Please quote”. Final availability, shipping and pricing are confirmed with your quotation.
A Moderna ionizable lipid used in investigational mRNA delivery platforms. Relevant to protein-replacement research and comparative studies of lipid structure and LNP performance.
3-[4,4-Bis(octyloxy)-1-oxobutoxy]-2-[[[[3-(diethylamino)propoxy]carbonyl]oxy]methyl]propyl (9Z,12Z)-9,12-octadecadienoate;CIN16645;[2-[3-(diethylamino)propoxycarbonyloxymethyl]-3-(4,4-dioctoxybutanoyloxy)propyl] (9Z,12Z)-octadeca-9;(9Z,12Z)-3-((4,4-Bis(octyloxy)butanoyl)oxy)-2-((((3-(diethylamino)propoxy)carbonyl)oxy)methyl)propyl octadeca-9,12-dienoate;LP01， LP 01
An ionizable lipid used for co-delivery of Cas9 mRNA and guide RNA. Studied in mouse liver-editing models, including transthyretin-targeting applications.
An ionizable lipid used for mRNA and siRNA delivery in vivo. Useful for comparing expression, gene silencing and inflammatory responses across LNP formulations.
ATX126， ATX 126,ATX 0126, ATX0126,ATX100,ATX-100, ATX 100
An ionizable lipid used in siRNA delivery formulations. Reported applications include hepatic Factor VII silencing in mice and comparative RNA interference studies.
An ionizable amino lipid used to package and deliver mRNA in LNPs. A benchmark material for formulation development, intracellular RNA delivery and vaccine research.
An established ionizable amino lipid for mRNA LNP formulations. Commonly used as a benchmark in vaccine-delivery research and comparative studies of cellular and in vivo expression.
An established ionizable lipid for siRNA delivery to the liver. Widely used as a benchmark in LNP formulation, gene-silencing and comparative RNA delivery research.
DLin-KC2-DMA;2,2-dilinoleyl-4-(2-dimethylaminoethyl)-[1,3]-dioxolane;DLinKC2DMA， DLin KC2 DMA
An ionizable lipid used in siRNA LNP formulations. Useful as a reference material for studying hepatic gene silencing and structure-dependent delivery potency.
2,5-Piperazinedione, 3,6-bis[4-[bis(2-hydroxydodecyl)amino]butyl]-;CKKE12， CKK E12
A multitail ionizable lipid investigated for RNA delivery to liver parenchymal cells. Supports comparative LNP screening and research on hepatic nucleic acid expression.
A widely used ionizable lipidoid for siRNA and mRNA delivery. Serves as a reference in LNP screening, hepatic delivery and nucleic acid formulation research.
di((Z)-non-2-en-1-yl) 9-((4-(dimethylamino)butanoyl)oxy)heptadecanedioate;bis[(Z)-non-2-enyl] 9-[4-(dimethylamino)butanoyloxy]heptadecanedioate;L319;starbld0004010;DA-64994;DGNMJYUPWDTKJB-ZDSKVHJSSA-N;LIPID L319?;EX-A5248;G16737;1351586-50-9;CS-0188740;MS-31081;GLXC-25938;LIPID L319;BP-28064;HY-139298;SCHEMBL517530;L-319， L 319 ， Lipid 319， lipid-319
A biodegradable ionizable lipid used for siRNA delivery. Useful for comparing hepatic gene silencing, lipid clearance and tolerability in preclinical LNP studies.
DLinDMA;1,2-dilinoleyloxy-n,n-dimethyl-3-aminopropane;WJB25812;1,2-dilinoleyloxy-3-dimethylaminopropane;E74884;1-Propanamine, N,N-dimethyl-2,3-bis[(9Z,12Z)-9,12-octadecadienyloxy]- (9CI);N,N-Dimethyl-2,3-bis[(9Z,12Z)-9,12-octadecadien-1-yloxy]-1-propanamine (ACI);1,2-Dilinoleyloxy-N,N-dimethylaminopropane;N,N-Dimethyl-2,3-bis(((9Z,12Z)-octadec-9,12-dien-1-yl)oxy)propan-1-amine;N,N-Dimethyl-2,3-bis[(9Z,12Z)-octadeca-9,12-dienyloxy]propan-1-amine,D-LinDMA， D-Lin-DMA;
An ionizable amino lipid used in LNP formulations for nucleic acid delivery. Useful as a reference material for studying lipid composition, RNA encapsulation and intracellular delivery.
PL40 is a cardiolipin-mimic lipid studied for antibody-free mRNA delivery to T cells. Its lipid nanoparticles support research on circular RNA delivery and in vivo CAR-T engineering, including preclinical studies of senescence-associated liver fibrosis and inflammatory arthritis.
A multiamine lipid platform for mRNA encapsulation and translation in LNPs. Its four ionizable nitrogen centers support studies of charge distribution, intracellular delivery and vaccine formulation.
A lipidoid studied for delivering CAR-encoding mRNA to primary mouse macrophages. Useful for research on transient macrophage engineering and cell-based cancer immunotherapy.
An ionizable lipid developed for mRNA delivery. Suitable for evaluating LNP formulation, cellular expression and delivery performance in comparative lipid screening.
A vitamin E-derived ionizable lipid developed by CureVac for nucleic acid delivery. Used to investigate LNP encapsulation, intracellular RNA release and vaccine delivery formulations.
An ALC-0315 analogue containing carbonate linkages. Useful for comparative studies of hydrolytic stability, membrane interactions and mRNA delivery across related ionizable lipid structures.
An SM-102 analogue containing carbonate linkages. A research candidate for comparing how linker chemistry and hydroxyl placement influence lipid degradation, LNP assembly and mRNA delivery.
An ionizable lipid investigated for systemic mRNA delivery to the central nervous system. CA2d-containing LNPs support preclinical studies of blood-brain barrier transport and functional RNA expression in brain cells.
2-Dodecanol, 1,1′-[[2-[2-[4-[2-[[2-[2-[bis(2- hydroxydodecyl)amino]ethoxy]ethyl](2- hydroxydodecyl)amino]ethyl]-1-piperazinyl] ethoxy]ethyl]imino]bis-,C12-4 (C12-494,Lipid A-4) ;C124， C12 4
A branched ionizable lipidoid studied for mRNA delivery to reproductive tissues in pregnant mice. Applications include placental gene expression and preclinical investigation of pregnancy-related delivery systems.
A furan-derived ionizable lipid investigated for CNS mRNA delivery through the meningeal lymphatic pathway after subcutaneous administration near cervical lymph nodes. Supports research on functional RNA delivery to neurons and glial cells.
A pH-switchable cationic lipid studied for siRNA delivery. Its conformational response to acidic conditions supports research on membrane fusion, endosomal escape and hepatic gene silencing.
A biodegradable ionizable lipid investigated for CNS genome-editing delivery after intrathecal administration. Supports preclinical studies of mRNA-based editing systems in neurons and astrocytes.
An imidazole-based ionizable lipid from the IMIL series. Studied for splenic mRNA expression and used as a comparator in structure-activity studies of spleen-directed delivery.
A tryptophan-derived ionizable lipid studied in self-amplifying RNA delivery systems. Its reported applications include experimental reprogramming of follicular helper T cells.
An imidazole-based ionizable lipid investigated for spleen-directed mRNA delivery. Supports research on splenic dendritic-cell transfection and immune-focused LNP formulations.
A biodegradable ionizable lipid studied in cholesterol-free LNPs for spleen-directed mRNA delivery. Relevant to splenic immune-cell transfection, including natural killer cells, and in vivo cell-engineering research.
An azide-functionalized SM-102 derivative for conjugation research. Its reactive handle supports click-chemistry attachment of labels or ligands and development of functionalized lipid delivery systems.
A thioketal-containing ionizable lipid investigated for ROS-responsive mRNA delivery to tumor cells. Useful for studying stimulus-triggered cargo release and preclinical cancer delivery systems.
An antioxidant ionizable lipid designed to combine mRNA delivery with protection against oxidative stress. Relevant to RNA stability, inflammatory disease models and regenerative delivery research.
A diketopiperazine-based ionizable lipid disclosed in patent literature for nucleic acid delivery. A research candidate for evaluating extrahepatic and hematopoietic-cell delivery formulations.
A dipeptide-modified lipid used in pancreatic-targeted LNP research. Following intraperitoneal administration, protein-associated particle assembly supports studies of organ-capsule filtration and pancreatic mRNA expression.
An albumin-binding lipid incorporating an Evans Blue-derived moiety. Investigated as an alternative surface component for lymphatic transport, lymph-node delivery and mRNA vaccine research.
A stereochemically defined diketopiperazine-based ionizable lipid. A candidate for studying extrahepatic mRNA delivery, including bone-marrow and immune-cell applications, in preclinical LNP systems.
1-methyl-4-piperidinecarboxylic acid, 11-[(2-hexyl-1-oxodecyl)oxy]-5-[6-[(2-hexyl-1-oxodecyl)oxy]hexyl]-5-hydroxyundecyl ester,CL-15-F6， CL15-F6
An ionizable cationic lipid used in mRNA LNPs and polymer-lipid hybrid nanoparticles for plasmid DNA delivery. Supports comparative studies of nucleic acid transfection platforms.
A patent-disclosed ionizable lipid from Generation Bio. A research candidate for investigating nucleic acid encapsulation, circulation behavior and delivery in sterically stabilized LNP formulations.
A patent-disclosed ionizable lipid investigated for localized mRNA expression after intramuscular administration. Relevant to muscle delivery and vaccine formulation research.
An ionizable lipid used in spleen-directed LNPs for immune-remodeling mRNA delivery. Supports preclinical studies of antigen-presenting-cell transfection, adaptive immune responses and cancer immunotherapy.
A Sail Biomedicine ionizable lipid investigated for spleen-favoring RNA delivery. Useful for comparing organ distribution and protein expression within related lipid series.
A Sail Biomedicine ionizable lipid investigated for spleen-directed delivery. Supports comparative studies of splenic expression, liver exposure and systemic RNA delivery performance.
An ionizable lipid used in CD8-targeted mRNA LNP systems. Supports research on transient CAR expression and T-cell engineering when combined with the appropriate targeting formulation.
A tripod-like lipid investigated for lung-directed mRNA and genome-editing delivery. Its reported applications include pulmonary epithelial-cell transfection following systemic administration in preclinical models.
An ionizable lipid used in PEG-free LNP research with tripolyphosphate stabilization. Relevant to alternative particle-stabilization strategies, mRNA encapsulation and hepatic delivery studies.
A branched ionizable phospholipid studied for hepatic mRNA delivery. Supports preclinical research on liver-directed protein expression and delivery of genome-editing payloads.
An ionizable lipid identified in screening for brain-directed mRNA delivery. Useful for studying how amine-core architecture and hydrophobic tail length influence LNP biodistribution.
A short-tail member of the CL15F ionizable lipid series. Supports research on how lipid branching and particle-surface composition affect protein interactions and organ-selective mRNA delivery.
A branched-tail CL15F-series ionizable lipid. Useful for comparing tail architecture, organ distribution and mRNA expression, including spleen and muscle delivery research.
An ionizable lipid investigated for mRNA delivery to immune cells in the spleen and bone marrow. Supports preclinical studies of immune-cell expression and formulation-dependent organ distribution.
A patent-disclosed Sail ionizable lipid investigated for spleen-favoring RNA delivery. Supports comparative biodistribution studies and development of immune-focused LNP systems.
A constrained ionizable cationic lipid disclosed in Capstan patent literature. Suitable for exploratory LNP formulation and structure-activity studies within the CICL family.
An ionizable lipid studied for mRNA-mediated protein expression. Reported applications include aerosolized pulmonary delivery in experimental emphysema models.
A patent-disclosed Sail ionizable lipid with reported splenic delivery applications. Useful for comparing organ distribution and expression across related ionizable lipid candidates.
An AA3-DLin-based lipid candidate investigated for mRNA cancer immunotherapy. Supports research on splenic dendritic-cell delivery and immune-cell reprogramming in appropriate formulations.
octanedioic acid, 1,1′-[2-[[[[3-(diethylamino)propoxy]carbonyl]oxy]methyl]-1,3-propanediyl] 8,8′-bis(1-octylnonyl) ester，VL-422， VL 422
An ionizable lipid used to deliver Cas9 mRNA and guide RNA in preclinical gene-editing studies. Applications include liver-directed editing of lipid-metabolism targets.
A biodegradable ionizable lipid investigated for spleen-directed delivery. Supports preclinical studies of mRNA expression in splenic macrophages and dendritic cells.
A degradable ionizable lipid studied for mRNA vaccine delivery. Relevant to cellular transfection, intramuscular expression and comparative evaluation of vaccine LNP formulations.
An Orna-associated ionizable lipid used in targeted RNA delivery research. A candidate for evaluating T-cell delivery within appropriately engineered LNP formulations.
A CICL-1-related ionizable lipid with a modified headgroup spacer. Useful for comparative studies of linker length, LNP assembly and nucleic acid delivery.
An anisamide-tethered lipidoid investigated for RNA delivery to activated fibroblasts. Supports research on ligand-directed delivery and preclinical liver-fibrosis applications.
A cholesterol-containing ionizable lipid investigated for mRNA delivery. Supports research on sterol incorporation, intracellular RNA release and biodegradable LNP design.
A pyridine carboxybetaine-modified ionizable lipid investigated in three-component LNPs. Useful for studying zwitterionic surface behavior, pH response and RNA delivery with simplified lipid compositions.
An ionizable amphiphilic Janus dendrimer that forms single-component mRNA delivery nanoparticles. Investigated for murine lung-parenchyma delivery and local protein-expression research.
A patent-disclosed ionizable amino lipid from MagicRNA. A research candidate for mRNA encapsulation, dendritic-cell transfection and intramuscular expression studies.
An ionizable lipid used to investigate formulation-dependent organ delivery. Changes in accompanying lipid components can shift mRNA accumulation and translation, supporting comparative liver and lung delivery research.
An ionizable lipid investigated for brain mRNA delivery after systemic administration. Supports research on receptor-associated blood-brain barrier transport and CNS expression in optimized LNP formulations.
A patent-disclosed ionizable lipid from JiaChen West Lake Biotech. Supports exploratory LNP formulation, mRNA expression and comparative lipid-delivery studies.
An Acuitas ionizable amino lipid used in nucleic acid delivery research. Relevant to liver-directed LNP formulations and delivery of mRNA-based gene-editing systems.
A biodegradable hyperbranched lipidoid investigated for spleen-directed mRNA delivery. Supports studies of lipid branching, splenic expression and immune-cell delivery.
A benzene-tricarboxamide-based cationic lipid investigated for mRNA delivery. A candidate for studying intracellular release and immune-focused delivery formulations.
A constrained ionizable cationic lipid from the Capstan series. Useful for exploratory formulation and comparative studies of nucleic acid delivery within the CICL family.
A tryptamine-derived ionizable lipid investigated for CNS mRNA delivery after intrathecal administration. Relevant to preclinical brain-cell transfection and local RNA delivery research.
A biodegradable ionizable lipidoid studied for route-dependent organ delivery. Supports comparative research on hepatic and pancreatic mRNA expression in appropriately formulated LNPs.
A cyclic-amine ionizable lipid investigated for mRNA delivery. Useful for studying how headgroup architecture and lipid packing influence particle properties and transfection.
An ionizable cationic lipid studied for liver-directed mRNA delivery. Reported applications include delivery of Cas9 mRNA and guide RNA for hepatic gene editing in mice.
An ionizable lipid developed through optimization of Lipid 88. Supports in vivo mRNA delivery research and comparative evaluation of related lipid structures.
A chloroquine-inspired ionizable lipid investigated for mRNA delivery and genome editing. Its quinoline-containing design supports studies of intracellular trafficking and endosomal release.
tetrakis(2-((((2-butyloctyl)oxy)carbonyl)oxy)ethyl) 3,3',3'',3'''-(((methylazanediyl)bis(propane-3,1-diyl))bis(azanetriyl))tetrapropionate;Lipid-88， Lipid 88
An ionizable lipid investigated for mRNA vaccine delivery. Supports studies of expression in lymphoid tissues and immune responses in preclinical vaccination systems.
A tri-oleoyl-Tris lipid used in formulation-dependent splenic B-cell delivery research. Relevant to protein-corona interactions and mRNA transfection of marginal-zone B cells.
((2-(pyrrolidin-1-yl)ethyl)azanediyl)bis(decane-1,2-diyl) dioctanoate
An ionizable lipid used for in vivo mRNA delivery. Applications include hepatic gene-editing research and expression of therapeutic proteins in preclinical LNP studies.
A branched-tail ionizable lipidoid with reported spleen-favoring delivery behavior. Useful for comparing organ distribution across related lipid structures and LNP formulations.
An ionizable lipid investigated for systemic mRNA delivery across the blood-brain barrier. MK16-containing LNPs support research on CNS expression and brain-cell delivery.
An ionizable lipid investigated for bone-marrow and hematopoietic-cell mRNA delivery. Supports preclinical research on systemic cell engineering using LNP formulations.
An ionizable lipid identified through the LUMI-lab discovery platform. Investigated for mRNA delivery, including lung-focused LNP research and comparison of computationally designed lipid candidates.
A biodegradable ionizable lipid developed through a modular Passerini-reaction platform. Studied for hepatic mRNA delivery, gene editing and repeat-dose protein-expression applications in preclinical models.
Heptadecan-9-yl 8-((2-hydroxyethyl)(4-(nonyloxy)-4-oxobutyl)amino)octanoate,Moderna-Lipid-26，Moderna Lipid-26
An ionizable cationic lipid used in preclinical mRNA vaccine formulations. Relevant to antigen expression and immune-response studies, including evaluation in nonhuman primates.
A disulfide-containing biodegradable ionizable lipid used for mRNA delivery. Useful for studying reduction-responsive degradation, endosomal release and intracellular expression.
6,9,28,31-Heptatriacontatetraen-19-ol, 19-[4-(dimethylamino)butyl]-, (6Z,9Z,28Z,31Z)-;YSK12C4， YSK12 C4
An ionizable lipid used in multifunctional envelope-type nanodevices for siRNA delivery. Supports studies of uptake, endosomal escape and gene silencing in immune cells.
An ALC-0315-related ionizable lipid associated with RNA-LNP delivery research. Applications include mRNA-encoded therapeutic antibodies and cancer immunotherapy formulations.
An SM-86-related ionizable lipid with modified hydrophobic tails. Useful for comparative LNP screening and investigation of tail-dependent RNA delivery properties.
L-829, L 829, Capstan-lipid-CICL-1, Capstanlipid CICL1, CICL1, CICL 1, CICL-1, Lipid 829, L-829, L 829, Compound A-11, DC60860
An ionizable lipid used in targeted LNP systems for T-cell mRNA delivery. Supports transient CAR-expression research when incorporated into appropriately targeted formulations.
An SM-86-related ionizable lipid incorporating an ether-containing tail. Investigated for siRNA delivery in liver-fibrosis research and comparison of hydrophobic-tail modifications.
An ionizable lipid investigated for localized mRNA expression after intramuscular administration. Supports research on muscle-focused delivery and reduction of expression in distant organs.
A glutathione-responsive, linker-degradable ionizable lipid studied for mRNA delivery. Useful for investigating reduction-triggered intracellular release and hepatic expression in preclinical LNP systems.
N,N'-(piperazine-1,4-diylbis(propane-3,1-diyl))bis(3-(didecylamino)propanamide);PPZA10， PPZ A10
An ionizable cationic lipid used for siRNA and mRNA delivery. Reported applications include RNA delivery to hepatic Kupffer cells and splenic macrophages following intraperitoneal administration in mice.
Moderna Lipid-29 Lipid29，Lipid 29,-[[8-[(1-ethylnonyl)oxy]-8-oxooctyl][3-[[2-(methylamino)-3,4-dioxo-1-cyclobuten-1-yl]amino]propyl]amino]-octanoic acid, 1-octylnonyl ester
An ionizable amino lipid used in mRNA LNP formulations. Applications include preclinical expression of erythropoietin and comparative protein-delivery studies.
Decan-2-yl 8-((8-(heptadecan-9-yloxy)-8-oxooctyl)(2-hydroxyethyl)amino)octanoate,Moderna-Lipid-48，Lipid-48，Lipid 48
A Moderna patent-disclosed ionizable amino lipid for mRNA delivery. Suitable for comparative LNP formulation and structure-activity research.
A Lipid 29 analogue intended for RNA delivery research. Supports comparative evaluation of mRNA or siRNA formulations within related ionizable lipid series.
Heptadecan-9-yl 8-((3-((2-(methylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)propyl)(8-(nonyloxy)-8-oxooctyl)amino)octanoate;Moderna-Lipid-compound-182，ModernaLipid compound182，lipid182，lipid 182，lipid-182
A Moderna patent-disclosed ionizable lipid related to Lipid 29. Useful for studying structural variation, mRNA encapsulation and intracellular expression in LNP formulations.
An Acuitas patent-disclosed ionizable amino lipid. Supports mRNA LNP development and comparative studies of amino-alcohol headgroups and ester-linked hydrophobic tails.
A Lipid 29 analogue for exploratory RNA delivery studies. Useful for comparing lipid structure, nanoparticle assembly and transfection behavior.
((4-Hydroxybutyl)azanediyl)bis(nonane-9,1-diyl) bis(2-butyloctanoate),Acuitas-Lipid III-25
An Acuitas patent-disclosed ionizable amino lipid investigated for mRNA delivery. Useful for comparative studies of hepatic expression and LNP formulation performance.
An Acuitas patent-disclosed ionizable amino lipid for mRNA delivery research. A candidate for LNP screening and structure-activity comparisons.
A branched-tail ionizable lipidoid investigated for formulation- and route-dependent mRNA delivery. Relevant to organ-selective delivery studies, including pulmonary and pancreatic applications.
An Acuitas patent-disclosed ionizable lipid for mRNA delivery. Supports exploratory formulation development and comparison with related amino-lipid candidates.
An acid-degradable cationic lipid used in responsive LNP systems. Relevant to pH-triggered particle disassembly and intracellular mRNA release studies.
A siloxane-containing lipid investigated for lung-directed mRNA delivery. Supports research on intracellular processing, endosomal escape and tissue-selective LNP design.
A degradable dendrimer-like lipid used for small-RNA delivery. Applications include hepatic gene silencing, tumor-delivery research and comparative nucleic acid formulation studies.
An ionizable lipid investigated for mRNA expression in immune cells across multiple organs. Supports comparative delivery studies involving liver, spleen and lung cell populations.
An ionizable lipid studied for mRNA transfection of T cells. Supports ex vivo engineering of transient CAR-expressing cells and comparison of nonviral delivery formulations.
An ionizable lipid investigated for Foxp3 mRNA delivery to CD4-positive T cells. Relevant to transient immune-cell reprogramming and regulatory T-cell research.
An ionizable lipid studied alongside C14-A1 for Foxp3 mRNA delivery to CD4-positive T cells. Useful for comparing tail-length effects on expression and cell viability.
A Genevant ionizable lipid investigated for mRNA delivery. Supports studies of protein expression, repeat administration and vaccine formulations in preclinical models.
An ionizable lipidoid studied for hepatic siRNA delivery. Applications include PCSK9 silencing and preclinical investigation of lipid-metabolism targets.
An Arcturus ionizable lipid used for siRNA delivery. Supports hepatic gene-silencing research, including Factor VII targeting in preclinical models.
A Genevant ionizable lipid investigated for mRNA LNP delivery. Useful for comparative studies of particle properties, intracellular expression and alternative lipid-linker chemistry.
A biodegradable ionizable lipid investigated for liver-directed RNA delivery. Supports preclinical studies of hepatic expression and formulation tolerability.
An ionizable lipid used in nucleic acid-lipid particles. Supports RNA interference research and comparative studies of related DLin-series delivery lipids.
An ionizable amino lipid used in RNA delivery research. Applications include experimental co-delivery systems for gene-editing components and comparative LNP formulation studies.
A biodegradable ionizable lipid studied for siRNA delivery. Useful for investigating tail structure, gene-silencing activity and degradation-dependent delivery properties.
An ionizable lipid used for mRNA and guide-RNA delivery. Reported applications include experimental CRISPR-mediated gene editing in skeletal muscle.
An ionizable lipid investigated for siRNA delivery with an emphasis on elimination behavior. Supports comparative studies of hepatic gene silencing and lipid disposition.
A multiprotic ionizable lipid studied for mRNA delivery. Useful for investigating staged protonation, endosomal processing and vaccine-formulation properties.
tetrakis(8-methylnonyl) 3,3',3'',3'''-(((methylazanediyl)bis(propane-3,1-diyl))bis(azanetriyl))tetrapropionate;306 Oi10, 306-Oi10
A branched-tail ionizable lipid used for mRNA LNP delivery. Supports studies linking tail architecture, surface ionization and intracellular expression.
A piperazine-containing ionizable lipid investigated for hepatic mRNA delivery. Useful for comparing delivery to hepatocytes and other liver-cell populations.
A lipid-like delivery material studied for siRNA and mRNA transport. Supports comparative evaluation of nucleic acid delivery in cellular and animal models.
RCB-4-8,RCB48， RCB 4 8,bis((Z)-12-(((non-2-yn-1-yloxy)carbonyl)oxy)octadec-9-en-1-yl) 3,3’-((2-(diethylamino)ethyl)azanediyl)dipropionate
A biodegradable ionizable lipid investigated for pulmonary mRNA delivery and genome editing. Supports research on lung-focused LNP formulations and local administration strategies.
A biodegradable alkyne-containing ionizable lipid studied for mRNA delivery. Reported applications include erythropoietin expression in preclinical renal-anemia research.
A biodegradable cyclic ionizable lipid studied for respiratory mRNA delivery. Relevant to nasal and pulmonary expression, epithelial-cell transfection and mucosal vaccine research.
A lipidoid studied for delivering CAR-encoding mRNA to primary mouse macrophages. Supports transient macrophage engineering and preclinical cell-immunotherapy research.
Benzeneacetic acid, 4-[[(9Z )-1-oxo-9-octadecen-1-yl]oxy]-, 1,1′-[dithiobis(2,1-ethanediyl-1,4-piperidinediyl-2,1-ethanediyl)] ester (ACI);ssPalmOPhe， ssPalmO Phe
A self-degradable ssPalm material for nucleic acid delivery. Supports research on intracellular particle disassembly, membrane transport and oligonucleotide release.
An ionizable lipidoid investigated in lymph-node-directed mRNA cancer-vaccine formulations. Supports research on antigen delivery and immune activation.
An ionizable lipid studied for mRNA vaccination. Relevant to antigen-presenting-cell activation and comparison of intradermal and intramuscular delivery formulations.
1H -Imidazole-2-carboxylic acid, 1-[3-(2-ethyl-1-piperidinyl)propyl]-5,5-di-(8Z )-8-heptadecen-1-yl-2,5-dihydro-, ethyl ester (ACI);A18ISO52DC18， A18 ISO5 2DC18
An ionizable lipid investigated for mRNA vaccine delivery with STING-pathway activation. Supports preclinical studies of delivery-associated immune stimulation and cancer vaccination.
An ionizable lipid for RNA delivery research. Useful for exploratory LNP formulation and comparative evaluation of related degradable lipid candidates.
A lipid-like compound studied for delivery of long mRNA payloads in vivo. Supports research on large-transcript packaging and functional protein expression.
An imidazole-based lipidoid investigated for mRNA and cGAMP delivery. Relevant to tumor-antigen cross-presentation, STING-associated immune activation and cancer immunotherapy research.
An ionizable lipidoid used in RNA LNP systems. Reported applications include hepatic delivery of CRISPR components and preclinical gene-editing research.
1H -Imidazole-2-carboxylic acid, 1-[3-(dimethylamino)propyl]-5,5-di- (8Z )-8-heptadecen-1-yl-2,5-dihydro-, ethyl ester (ACI);A12Iso52DC18， A12 Iso5 2DC18
An amine-containing lipid investigated for mRNA delivery and STING-pathway activation. Supports experimental vaccine formulation and antitumor immune-response research.
A disulfide-containing ionizable lipidoid used in mRNA LNP formulations. Useful for comparing biodegradable lipid structures and intracellular delivery behavior.
Decanoic acid, 2-hexyl-, 1,1′-[[[3-(1H -imidazol-1-yl)propyl]imino]di-6, 1-hexanediyl] ester (ACI),Lipid A26,ORNA Lipid 10a26
An Orna-associated ionizable lipid investigated for RNA delivery in immune-focused LNP formulations. Supports studies of splenic and circulating immune-cell expression.
bis(2-(octyldisulfaneyl)ethyl) 3,3'-((4-methyl-11-oxo-12-oxa-15,16-dithia-4,8-diazatetracosyl)azanediyl)dipropionate;306O12B3，306 O12B 3
An ionizable lipidoid used for antisense oligonucleotide delivery. Applications include hepatic PCSK9 silencing and combination-lipid systems investigated for brain-directed antisense delivery.
N-[3-(dimethylamino)propyl]-N-[3-[2-(dodecyldithio)ethoxy]-3-oxopropyl]-β-alanine, 2-(dodecyldithio)ethyl ester,80O16B， 80 O16B
A disulfide-containing ionizable lipidoid studied for delivery of gene-editing and mRNA payloads. Also investigated in ligand-modified nanoparticles for tumor-delivery research.
A tryptamine-containing lipidoid used in combination delivery systems. Investigated for brain-directed antisense oligonucleotide delivery and reduction of tau expression in mice.
piperazine-1,4-diylbis(ethane-2,1-diyl) (9Z,9'Z,12Z,12'Z)-bis(octadeca-9,12-dienoate);AA3DLin， AA3 DLin
An ionizable amino lipid used in mRNA LNP formulations. Relevant to vaccine-delivery research and comparative studies of antigen expression and immune responses.
Piperidine, 1-methyl-4,4-bis[(9Z,12Z)-9,12-octadecadien-1-yloxy]-;YSK-05，YSK05
A pH-sensitive cationic lipid used in siRNA delivery systems. Supports research on endosomal escape and gene silencing, including PEG-containing formulations.
((2-hydroxyethyl)azanediyl)bis(octane-8,1-diyl) bis(2-hexyldecanoate).ALC0315 analogous1， ALC 0315 analogous 1
An ALC-0315-related lipid for comparative delivery research. Useful for studying how structural modifications affect LNP formulation and nucleic acid transport.
An ALC-0315 analogue for LNP research. Useful for comparing formulation behavior and RNA delivery across related ionizable amino-lipid structures.
An ALC-0315-related ionizable lipid with ester-linked hydrophobic tails. Supports exploratory studies of structural variation, degradation and RNA delivery.
An ionizable amino lipid used to formulate LNPs. Suitable for exploratory nucleic acid delivery studies and comparative lipid screening.
2-[Di-(9Z,12Z)-9,12-octadecadien-1-ylamino]ethyl 4-(dimethylamino)butanoate;Lipid-8，Lipid8
An ionizable lipid studied in LNP systems for cancer-associated gene-editing delivery. Applications include preclinical tumor models using appropriately formulated or targeted particles.
bis(2-(tetradecyloxy)ethyl) 3,3'-((3-(1H-imidazol-1-yl)propyl)azanediyl)dipropionate;93O17O， 93 O17O
A chalcogen-containing lipidoid studied for splenic delivery and intracellular cargo transport. Applications include genome-editing payloads and experimental cancer immunotherapy.
1,1',1'',1'''-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(azanetriyl))tetrakis(tetradecan-2-ol),IC8， IC 8
An ionizable lipid used in mRNA LNP research. Reported applications include vaccine formulations and expression of therapeutic immune-engaging proteins in preclinical tumor models.
An SM-102 analogue for comparative mRNA delivery research. Useful for studying how ester position and hydrophobic-tail design influence LNP formulation and expression.
ethyl 5,5-di((z)-heptadec-8-en-1-yl)-1-(3-(pyrrolidin-1-yl)propyl)-2,5-dihydro-1h-imidazole-2-carboxylate, A2Iso52DC18， A2 Iso5 2DC18
An ionizable lipid investigated for mRNA delivery to dendritic cells, macrophages and cultured tumor cells. Supports comparative transfection studies and immune-focused formulation development.
An ethanolamine-based ionizable lipid with ester-containing hydrophobic tails. Useful for exploratory mRNA delivery and comparison of linker placement across lipid analogues.
An ionizable lipid with a propanolamine headgroup and ester-containing tails. A candidate for mRNA formulation and comparative structure-activity studies.
An ionizable lipid investigated for mRNA delivery in cancer immunotherapy models. Reported applications include expression of an IL-2 fusion protein in preclinical tumor studies.
An ionizable lipid used in nucleic acid-lipid particles. Relevant to siRNA encapsulation, liposome formulation and comparative delivery studies.
N,N-Dimethyl-β-alanine (10Z,13Z)-1-(9Z,12Z)-9,12-octadecadien-1-yl-10,13-nonadecadien-1-yl ester;DLinMC2DMA， DLin MC2 DMA
A DLin-series ionizable lipid used for siRNA delivery research. Supports comparison of lipid structure, particle formulation and gene-silencing behavior.
A DLin-series ionizable lipid investigated for siRNA delivery. Useful for structure-activity comparisons with related amino-lipid delivery materials.
An amine-containing lipidoid investigated as a carrier for polynucleotides. Supports exploratory nanoparticle formulation and comparative nucleic acid delivery studies.
A neurotransmitter-derived lipidoid studied in mixed-lipid systems for brain delivery. Supports preclinical research on blood-brain barrier transport, neuronal gene silencing and recombination.
An ionizable lipid used in liposomal delivery systems. Relevant to encapsulation of siRNA, antisense oligonucleotides and other therapeutic research cargos.
A biodegradable ionizable lipid investigated for mRNA delivery. Supports studies of intramuscular vaccine expression, lymph-node delivery and lipid clearance in preclinical formulations.
An ionizable sterol lipid investigated in three-component LNPs without added free cholesterol. Supports research on localized mRNA expression after intramuscular administration and vaccine delivery.
A three-tail structural analogue of A5-CE-C7-6, containing carbonate-linked hydrophobic chains. Useful as a control for comparing tail number, LNP assembly and RNA delivery with the parent two-tail lipid.
An imidazole-functionalized cholesterol lipid used in nucleic acid delivery formulations. Relevant to pH-responsive membrane design and pulmonary mRNA delivery research.
A cholesterol-derived cationic lipid used in charge-reversible amphoteric liposomes. Applications include antisense oligonucleotide delivery and studies of pH-dependent membrane behavior.
A noncationic thiourea lipid that associates with nucleic acids through hydrogen bonding. Supports research on alternative RNA packaging mechanisms, intracellular delivery and cancer-vaccine formulations.
A longer-chain analogue of the PEG lipid ALC-0159. Useful for investigating PEG-lipid retention, colloidal stability, protein interactions and circulation behavior in LNP formulations.
An acid-degradable PEG lipid for responsive LNP formulations. Useful for studying pH-dependent PEG shedding, particle stability and intracellular RNA delivery.
An acid-degradable anionic lipid used in responsive LNP research. Supports studies of charge composition, endosomal degradation and mRNA release.
DOTAP; DOTAP chloride; N-(1-(2,3-Dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride; (+/-)-Dotap chloride， DOTAP-Cl
A permanently cationic lipid used in liposomes and nucleic acid delivery formulations. Supports DNA and RNA transfection and studies of charge-dependent particle behavior.
N,N-Dimethyl-N-octadecyloctadecan-1-aminium bromide;Dimethyldi-n-octadecylammonium bromide;dimethyl(dioctadecyl)azanium,bromide;Dimethyldioctadecylammonium (Bromide Salt);DIMETHYLDIOCTADECYLAMMONIUM BROMIDE;Dimethyldistearylammonium Bromide;Dioctadecyl Dimethyl Ammonium Bromide;Distearyldimethylammonium bromide;DODMAB;DDAB;DODAB;1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, bromide;distearyl dimethyl ammonium bromide;1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, bromide (1:1);Z5T47R065A;Dimethyldioctadecylammonium bromide, 99+%;DSAB;C38H80N.Br;dimethyldioctadecylazanium bromide;C38H80BrN,DODAB， DODA(Br)
A cationic lipid used in vesicle and delivery-system research. Useful for investigating electrostatic cargo association and the influence of lipid charge on particle properties.
DOTMA;Trimethyl[2,3-(dioleyloxy)propyl]ammonium Chloride;N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium;2,3-bis[(Z)-octadec-9-enoxy]propyl-trimethylazanium;chloride;DOTMA?;N-[1-(2,3-Dioleyloxy) Propyl]-N,N,N-trimethylammonium Chloride;1-Propanaminium, N,N,N-trimethyl-2,3-bis(9-octadecenyloxy)-, chl;E85159;N-[1-(2,3-Dioleyloxy)propyl]-N,N,N-trimethylammonium Chloride;DOTMA, 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt), chloroform;SCHEMBL156278;PD088777;DA-63002;N-[1-(2 pound not3-Dioleyloxy)propyl]-N pound notN pound notN-trimethylammonium Chloride;T1307;BP-25706;DOTMA, 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt), powder;BS-51321;104162-48-3;MFCD00145456;104872-42-6;N,N,N-Trimethyl-2,3-bis((Z)-octadec-9-en-1-yloxy)propan-1-aminium chloride;1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt);HY-W127644;J-001121;N-(1-(2,3-Dioleyloxy)propyl)-N,N,N-trimethylammonium chloride;EX-A5047;1-Propanaminium, N,N,N-trimethyl-2,3-bis(9-octadecenyloxy)-, chloride, (Z,Z)-;CS-0185844
A permanently cationic lipid used for in vitro nucleic acid transfection. Supports liposomal delivery studies involving RNA and oligonucleotide cargos.
SM-102 N-oxide, supplied as a research reference material.
No matching products. Try another name, catalog number, CAS or alias, or reset the filters.
COMPLETE YOUR ORDER
Explore complementary products and include the components you need in your inquiry.
A SIMPLE NEXT STEP
Choose products, specify pack sizes and quantities, then review and copy or download your inquiry. Use “Selected products only” to check your selection before sending.
We match the best price and quality on market.
